Close
Smartlab Europe
Inizio Ignite

Press Releases

Pistoia Alliance Launches New DataFAIRy: Bioassay Project to Make More Data Machine-Readable and to Drive AI Adoption

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, launches the second phase of its DataFAIRy: Bioassay project, which aims to convert bioassay data into machine-readable formats that adhere to the FAIR...

Syntegon launches new pick-and-place platform

The Covid-19 pandemic has further fueled the automation megatrend. Manufacturers of different products, especially food, increasingly rely on robotic solutions to automate critical process steps or to fully automate entire systems. Syntegon Technology has been offering robotic solutions for...

Clinerion adds aggregate patient metrics for the real-world data on Patient Network Explorer with the RWD RADAR service

Clinerion’s RWD RADAR offers daily-updated, aggregate metrics on patient cohorts and the patient journey, including usage of terminologies, covering diagnoses, medications, laboratory tests, and procedures, across the Patient Network Explorer hospital network. Supporting epidemiological research, RWD RADAR generates patient cohort...

Quanticate Launches Updated Remote Source Data Verification (RSDV) Platform

Quanticate, a leading global data-focused clinical research organisation (CRO), has launched a new Remote Source Data Verification (RSDV) Platform. The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical research sites’ source data to be completed remotely...

BIO Asia – Taiwan 2021 Conference and Exhibition to be held as scheduled

The Taiwan Bio Industry Organization (Taiwan BIO) together with the Global Biotechnology Innovation Organization (BIO) jointly announced that BIO Asia–Taiwan 2021 will be held as scheduled from July 21 to 25, with pre-opening access beginning July 19. Such access...

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase. These biochemical abnormalities, identified by a...

Phesi data show clinical trial suspensions continue to rise as covid-19 impact on development persists

Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back following suspension in March and April 2020. Phesi’s previous analysis in May 2020 found that...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »